 |
|
|
ABSTRACTS
Call for Abstracts: International Congress XXII
Submission Deadline: August 31, 2008
International Congress is the premier conference on endovascular technologies and techniques. We’re committed to maintaining the leading-edge reputation of the International Congress series and encourage the medical community to submit new and timely information. The Abstract Review Committee will select the truly superior abstracts for inclusion in the Scientific Sessions.
Abstract Specifications:
Abstracts must be a concise, substantive abbreviation of the material to be presented, including purpose, methods, results and significance of findings.
Abstracts should be one page (300 words maximum) with the name of the presenting author underlined. Include the institution, city, state and country of the senior author. Provide the name, address, and telephone and fax numbers, as well as the email address of the corresponding author.
Abstracts will be reviewed to ensure balance, independence and objectivity. To that end, authors are required to disclose:
- All relevant financial relationships with commercial supporters.
- Whether you intend to discuss an investigational product or the off-label use of a commercial product.
- Whether recommendations involving clinical medicine are based on evidence that is accepted within the profession of medicine as adequate justification for indications and contraindications in the care of patients.
- That all scientific research referred to, report or used in support or justification of a patient care recommendation conforms to the generally accepted standards of experimental design, data collection and analysis.
Submit Abstracts to:
Veronica Baez |
|
| Address | International Congress XXII 2632 North 20th Street Phoenix, Arizona 85006 USA |
| Phone | 1.602.707.4403 |
| Fax | 1.602.265.8885 |
| vbaez@azheart.com | |